These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 5786008)
21. What's happening to biomedical engineering in Canada? Hopps JA Med Prog Technol; 1974; 2(4):177-82. PubMed ID: 4855418 [No Abstract] [Full Text] [Related]
22. Commercialization of academia research. Jamali F J Pharm Pharm Sci; 1999; 2(3):88. PubMed ID: 10953253 [No Abstract] [Full Text] [Related]
23. Funding on 'Sheriff of Nottingham' model could cut productivity. Currie D Nature; 2009 Oct; 461(7268):1198. PubMed ID: 19865143 [No Abstract] [Full Text] [Related]
24. [Financing of education and research in universities]. Hálek J Sb Lek; 1998; 99(4):625-30. PubMed ID: 10803313 [TBL] [Abstract][Full Text] [Related]
25. Commentary: an independent voice?: conflicts of interest and research on ethical, legal and social issues. Caulfield T Health Law Rev; 2005; 13(2-3):114-6. PubMed ID: 16459424 [No Abstract] [Full Text] [Related]
26. The challenge of private biomedical research funding in Italy. Bordignon C Nat Med; 1999 Feb; 5(2):135-7. PubMed ID: 9930852 [No Abstract] [Full Text] [Related]
27. Public-private partnerships in biomedical research: resolving conflicts arising under the Federal Technology Transfer Act of 1986. Bulleit TN J Law Health; 1989-1990; 4(1):1-20. PubMed ID: 11652568 [No Abstract] [Full Text] [Related]
28. Drug discovery: new models for industry-academic partnerships. Tralau-Stewart CJ; Wyatt CA; Kleyn DE; Ayad A Drug Discov Today; 2009 Jan; 14(1-2):95-101. PubMed ID: 18992364 [TBL] [Abstract][Full Text] [Related]
29. Canadian budget. Graduate training, research councils are big winners. Kondro W Science; 2003 Feb; 299(5611):1298. PubMed ID: 12610268 [No Abstract] [Full Text] [Related]
31. After slow start, project to channel drug company funds to universities builds steam. Berkowitz P CMAJ; 1996 Aug; 155(3):318-20. PubMed ID: 8705914 [TBL] [Abstract][Full Text] [Related]
32. Grant proposal reviewer says he would have scored proposal lower due to conflict of interest. Maloney DM Hum Res Rep; 2004 Dec; 19(12):8. PubMed ID: 15810180 [No Abstract] [Full Text] [Related]
33. The role and responsibility of industry in research. Lasagna L Dolentium Hominum; 1987; 4(2nd Yr. 1):56-9. PubMed ID: 11653199 [No Abstract] [Full Text] [Related]
34. Commercial support and bias in pharmaceutical research. Landefeld CS Am J Med; 2004 Dec; 117(11):876-8. PubMed ID: 15589496 [No Abstract] [Full Text] [Related]
35. Researcher said his colleague should have revealed possible conflicts of interest. Maloney DM Hum Res Rep; 2005 Jan; 20(1):8. PubMed ID: 15810184 [No Abstract] [Full Text] [Related]
36. Relationships between the academic community and the pharmaceutical industry: the legislative background and its effect on spending on medical research and development. Matthews JH Clin Invest Med; 1996 Dec; 19(6):470-8. PubMed ID: 8959357 [TBL] [Abstract][Full Text] [Related]
37. University physician-researcher conflicts of interest: the inadequacy of current controls and proposed reform. Maatz CT High Technol Law J; 1992; 7():137-88. PubMed ID: 11659962 [No Abstract] [Full Text] [Related]
39. Canadian Society for Clinical Investigation representation to the Eastman Commission: research and development in the pharmaceutical industry--a Sisyphyian tale. MacLeod SM Clin Invest Med; 1986; 9(2):133-6. PubMed ID: 3731578 [No Abstract] [Full Text] [Related]
40. Industry and academia in transition. Kennedy D Science; 2003 Nov; 302(5649):1293. PubMed ID: 14631000 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]